Intellia Therapeutics, Inc.NTLANASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 58 | 33↓43.0% | 52↑57.7% | 36↓30.4% | 58↑59.6% |
| Gross Profit | -92 | 26↑128.3% | 45↑70.3% | 27↓38.7% | 48↑74.3% |
| Operating Income | -137 | -268↓96.1% | -458↓71.1% | -515↓12.5% | -534↓3.7% |
| Net Income | -134 | -268↓99.6% | -474↓77.0% | -481↓1.5% | -519↓7.9% |
| EBITDA | -130 | -261↓100.3% | -451↓72.7% | -506↓12.4% | -524↓3.5% |
| EPS Diluted | -2.40 | -3.78↓57.5% | -6.16↓63.0% | -5.42↑12.0% | -5.25↑3.1% |